Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Analgesics in

Analgesics in the US

22 pages, Nov 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Category benefits from the country’s ageing population

Demand for analgesics in the US remains steady as consumers look to treat ailments such as headaches, minor aches and pains and fever. The occurrence of these conditions is determined by many factors, including the increasing prevalence of chronic conditions such as cancer, obesity and heart disease.

Topical analgesics/anaesthetic appeal to more active consumers

In the US, healthy and active lifestyles are growing in popularity amidst rising rates of obesity and chronic disease. Aches and pains often accompany physical activity, thus helping to drive demand for analgesics, particularly topical products.

Potential side-effects can dictate consumer demand for different types of analgesic

In 2015, the US Food and Drug Administration (FDA) revised its over-the-counter (OTC) Drug Facts label warning for non-steroidal anti-inflammatory drugs (NSAIDs), which include aspirin, naproxen and ibuprofen. While the label already included a warning that the use of NSAIDs may increase the risk of heart attack and stroke, the FDA sought to include additional details concerning risks related to dosage and length of use.

COMPETITIVE LANDSCAPE

Aleve provides no relief for Bayer

In 2017, Bayer Corp, the third leading player in analgesics, stood out from its competitors by recording a retail value sales decline. This was partly down to the company’s signature analgesics brand Aleve (naproxen).

Strongest performing players reflect shift to topical products

Topical analgesics/anaesthetic manufacturers, including Chattem (Icy Hot, Aspercreme, Capzasin), Hisamitsu America (Salonpas), NFI Consumer Products (Blue-Emu) and Performance Health (Perform), recorded much stronger value sales growth than most other analgesics players in 2017. Chattem remained the clear leader in topical analgesics/anaesthetic but faced strong competition over the review period as manufacturers launched new products.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Analgesics Market Sample Report Analgesics Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in USA with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in USA market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Analgesics in USA?
What are the major brands in USA?
Are combination products with acetaminophen still popular?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Analgesics in the US - Category analysis

HEADLINES

PROSPECTS

Category benefits from the country’s ageing population

Topical analgesics/anaesthetic appeal to more active consumers

Potential side-effects can dictate consumer demand for different types of analgesic

COMPETITIVE LANDSCAPE

Aleve provides no relief for Bayer

Strongest performing players reflect shift to topical products

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2012-2017
Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Consumer health products remain popular in the US as lifestyles and demographics dictate the success of various categories

Changing lifestyles provide a roadmap for success in consumer health

Competition is fierce in a fragmented consumer health market

The power of the internet derives from convenience, choice and customisation

The health conditions which accompany ageing are central to future demand

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2016-2017

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Analgesics in the US

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Category benefits from the country’s ageing population

Topical analgesics/anaesthetic appeal to more active consumers

Potential side-effects can dictate consumer demand for different types of analgesic

COMPETITIVE LANDSCAPE

Aleve provides no relief for Bayer

Strongest performing players reflect shift to topical products

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Analgesics in the US - Category analysis

HEADLINES

PROSPECTS

Category benefits from the country’s ageing population

Topical analgesics/anaesthetic appeal to more active consumers

Potential side-effects can dictate consumer demand for different types of analgesic

COMPETITIVE LANDSCAPE

Aleve provides no relief for Bayer

Strongest performing players reflect shift to topical products

CATEGORY DATA

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Consumer health products remain popular in the US as lifestyles and demographics dictate the success of various categories

Changing lifestyles provide a roadmap for success in consumer health

Competition is fierce in a fragmented consumer health market

The power of the internet derives from convenience, choice and customisation

The health conditions which accompany ageing are central to future demand

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports